1Ross R. Atherosclerosis- an inflammatory disease[J]. N Engl J Med , 1999 , 340 : 115 - 126.
2Blann AD. Dobrotova M. Kubisz P, et al. yon Willebrand factor, soluble P- seleetin,tissue plasmirogen activator and plasminogen activator inhibitor in atherosclerosis[J]. Thromb Haemost 1995,74:626 - 630.
3Blankenberg S. Ruppercht HJ. Bickel C, et al , Circulating cell adhension molecules and death in patients with coronary artery disease [J]. Criculation 2001, 104(12) :1336 - 1342.
4Biasucci L. Liuzzo G. Fantuzzi G, et al. Increasing levels of interleukin (IL) -1 Ra and IL- 6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in - hospital coronary events. Circulation. 1999,99:2074 - 2084.
5Ridker P. Rifai N. Pfeffer M, et al. Elevation of tumor necrosis factor - alpha and increased risk of recurrent coronary events after myocardial infarction[J]. Circulation ,2000 ,101 (8) :21492-21531.
6Galis ZS . Muszynski M. Sukhova GK, et al. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of humanatherosclerotic lesions. Ann N Y Acad Sci , 1995 , 748 : 501 -507.
7Galls ZS . Sukhova GK. Kranzhofer B , et al. Macrophage foam cells from experimental atheroma constitutively produce matrix degrading proteinase. Proc Natl Acad Sci USA , 1995 , 92 : 402 -406.
8Herman MP. Sukhova GK. Libby P , et al. Expression of neutrophil collagenase (matrix metalloproteinase- 8 ) in human atheroma : a novel collagenolytic pathway suggested by transcriptional profiling. Circulation , 2001 , 104 : 1 899-904.
9Lagrand WK. Niessen HW . Wblbink GJ , et al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction[J]. Circulation, 1997,95:97 - 103.
